09:38 EST NovoCure trading resumes
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on NVCR:
- NVCR Earnings Report this Week: Is It a Buy, Ahead of Earnings?
- NovoCure’s Lung Cancer Therapy Application Accepted by FDA
- FDA accepts Novocure PMA application for TTFields therapy in NSCLC
- Novocure enrolls final patient in TRIDENT clinical trial
- Novocure sees FY23 revenue $509.3M, consensus $505.05M